RHHBY

OTC · Healthcare

Roche Holding AG

Q: Where is RHHBY trading today?

RHHBY last closed at $47.39, down 2.12% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $231.90 and a high of $374.90. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Q: What are analyst ratings for RHHBY stock?

Among 29 analysts covering RHHBY, the consensus rating is Hold — 15 rate it a buy, 9 hold, and 5 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Q: How much revenue does Roche Holding AG generate?

Roche Holding AG generated $387.82B in revenue during fiscal year 2026, with $82.47B reaching the bottom line as net income. The net profit margin of 13.7% is solid for its sector.

Q: What is the price-to-earnings ratio for RHHBY?

RHHBY trades at a P/E ratio of 20.01 on trailing earnings of $16.04 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

Mega-Cap Stocks Blue Chip Stocks Best Dividend Stocks Highest Dividend Yield

$47.39

-1.03 (-2.12%)

As of Mar 22, 11:07 PM ET ·

Day Range $47.05 — $48.88

52W Range $231.90 — $374.90

Open$48.85

Previous Close$48.41

Day High$48.88

Day Low$47.05

52W High$374.90

52W Low$231.90

Volume—

Avg Volume1.59M

Market Cap257.69B

P/E Ratio20.01

EPS$16.04

SectorHealthcare

Analyst Ratings

Hold

29 analysts

15 Buy 9 Hold 5 Sell

Key Financials

	FY 2026	FY 2025
Revenue	387.82B	392.69B
Net Income	82.47B	75.15B
Profit Margin	13.7%	13.0%
EBITDA	110.61B	106.40B
Free Cash Flow	—	—
Rev Growth	-1.2%	-1.2%
Debt/Equity	0.98	0.98

Dividend

Dividend Yield3.02%

Annual Dividend$10.54

Payout Ratio65.1%

Frequencyquarterly

Ex-Dividend—

Pay Date—

Healthcare Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
AZN	AstraZeneca PLC	$183.60	-2.82%	28.6	218.85B
NVS	Novartis AG	$146.03	-1.46%	20.0	222.45B
SNY	Sanofi	$44.60	-1.63%	7.5	94.09B
GSK	GSK plc	$52.97	+1.89%	13.7	78.27B
NVO	Novo Nordisk A/S	$38.58	+1.63%	10.3	1.06T

RHHBY Frequently Asked Questions

Where is RHHBY trading today?

RHHBY last closed at $47.39, down 2.12% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $231.90 and a high of $374.90. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

What are analyst ratings for RHHBY stock?

Among 29 analysts covering RHHBY, the consensus rating is Hold — 15 rate it a buy, 9 hold, and 5 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

How much revenue does Roche Holding AG generate?

Roche Holding AG generated $387.82B in revenue during fiscal year 2026, with $82.47B reaching the bottom line as net income. The net profit margin of 13.7% is solid for its sector.

What is the price-to-earnings ratio for RHHBY?

RHHBY trades at a P/E ratio of 20.01 on trailing earnings of $16.04 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.